We propose an approach for investigating the etiology of hypophosphatemia along with an illustrative case of a 29-yr-old female with PHEX PV-negative FGF23-mediated hypophosphatemic osteomalacia responding well to burosumab. This evidence concerns the gene FGF23 and hypophosphatemia.